November Social Media Round-Up—Access to Medicine Foundation Index, Fortune’s 100 Most Powerful People in Business, and More
The year may be winding down, but Pfizer stayed busy on social media throughout November.
CEO Albert Bourla celebrated the company’s fourth place ranking in the 2024 Access to Medicine Foundation Index—moving up two spots from the previous year—while Bourla himself was recognized in Fortune’s inaugural 100 Most Powerful People in Business. The CEO also proudly announced current Chief Oncology Officer Chris Boshoff’s ascension into the role of Chief Scientific Officer and President, R&D effective January 1, 2025. Meanwhile, our leadership honored the efforts of Pfizer colleagues, welcomed a new colleague, and more.
Check out those updates then head over to our corporate social channels to catch up on an episode of “Dear Scientist,” the latest film in our “Race Against Resistance” series, and the launch of our new series the Pfizer Specialty “Voices of Innovation.”
Follow our channels and see more updates below!
Executive Leadership
- CEO Albert Bourla proudly shares Pfizer’s inclusion in the top 5 pharma companies in the 2024 Access to Medicine Foundation Index
- Chief U.S. Commercial Officer Aamir Malik recognizes the Pfizer Multicultural Health Equity Collective’s second Health Equity in Action Summit and its efforts to address health inequities
- CEO Albert Bourla announces Chief Oncology Officer, Chris Boshoff, will be appointed as Pfizer’s Chief Scientific Officer and President of Research & Development in the new year
- Chief Oncology Officer Chris Boshoff shares his excitement to step into a new role in January as Pfizer’s Chief Scientific Officer and President R&D
- Chief Scientific Officer Mikael Dolsten congratulates the Pfizer PAXLOVID team for being honored in the Prix Galien USA 2024 award for Best Pharmaceutical Product
- Chief Oncology Officer Chris Boshoff welcomes Dr. Johanna Bedell who will join Pfizer in 2025 as the Chief Development Officer, Oncology
- CEO Albert Bourla honors the millions of veterans across the country who have served our nation on Veteran’s Day
Pfizer on LinkedIn
- Pfizer’s CEO Albert Bourla is recognized in Fortune’s inaugural 100 Most Powerful People in Business
- Pfizer partners with Patrick Dempsey and the American Cancer Society to host “Front Porch Conversations,” connecting with those in rural America impacted by cancer
- Pfizer holds our annual DE&I summit bringing together thought leaders, colleagues, and partners to foster diversity, equity, and inclusion
- Pfizer launches the Pfizer Specialty “Voices of Innovation” series, interviewing leaders across the healthcare ecosystem with a focus on rare disease, inflammation & immunology, and hospital care
- Pfizer observes Trans Day of Remembrance in memory of the lives lost to anti-transgender violence
- Pfizer shares the medical advancements being made in the management of hemophilia
- Pfizer partners with The Drone Racing League who share our commitment to innovating through technology, reaching millions of young people that gravitate to STEM
Pfizer on Instagram
- Pfizer takes you along with therapy dog team, Walter and Kara, who bring comfort to patients with cancer and share the importance of early detection
- Pfizer shares the patient story of Kimberly and her journey raising awareness for cervical cancer and increasing representation for people of color
- Hear the story of Bill and his caregiver, Connie, as they navigate a lung cancer diagnosis and raise awareness for others in the community for Lung Cancer Awareness Month
Pfizer on X
- Pfizer’s Head of ADC Discovery shows you what’s next in lung cancer research in the latest episode of “Dear Scientist”
- Pfizer’s latest film in the “Race Against Resistance” series takes you through the risks of antimicrobial resistance in patients with cancer
Pfizer on TikTok